Effect of Intensive Lipid Lowering with Atorvastatin on Renal Function in Patients with Coronary Heart Disease
- 1 November 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 2 (6), 1131-1139
- https://doi.org/10.2215/cjn.04371206
Abstract
Background and objectives: Data suggest that atorvastatin may be nephroprotective. This subanalysis of the Treating to New Targets study investigated how intensive lipid lowering with 80 mg of atorvastatin affects renal function when compared with 10 mg in patients with coronary heart disease.Keywords
This publication has 42 references indexed in Scilit:
- Renal Function and Risk of Myocardial Infarction in an Elderly PopulationArchives of Internal Medicine, 2005
- Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial InfarctionNew England Journal of Medicine, 2004
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Kidney Disease as a Risk Factor for Development of Cardiovascular DiseaseCirculation, 2003
- National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and StratificationAnnals of Internal Medicine, 2003
- Effect of Pravastatin on Loss of Renal Function in People with Moderate Chronic Renal Insufficiency and Cardiovascular DiseaseJournal of the American Society of Nephrology, 2003
- MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trialThe Lancet, 2003
- Editorial boardAmerican Journal of Kidney Diseases, 2003
- Impact of renal failure on the risk of myocardial infarction and deathKidney International, 2002
- Effect of lipid reduction on the progression of renal disease: A meta-analysisKidney International, 2001